We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+12.05%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
AUM
$4.84B
AUM Growth
-$84.2M
Cap. Flow
-$434M
Cap. Flow %
-8.96%
Top 10 Hldgs %
17.01%
Holding
228
New
50
Increased
48
Reduced
84
Closed
46

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$77.5M
2
WAB icon
Wabtec
WAB
+$43.6M
3
CE icon
Celanese
CE
+$41.2M
4
ZBRA icon
Zebra Technologies
ZBRA
+$37.4M
5
CPE
Callon Petroleum Company
CPE
+$37.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.9M
2
RCL icon
Royal Caribbean
RCL
+$54.7M
3
XYZ
Block Inc
XYZ
+$53.8M
4
EFOR
Everforth Inc
EFOR
+$51.7M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$43.7M

Sector Composition

Rank Sector Weight
1 Technology 24.26%
2 Consumer Discretionary 16.62%
3 Healthcare 14.91%
4 Financials 12.59%
5 Industrials 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTEK icon
176
Tetra Tech
TTEK
$9.07B
$2.92M 0.06%
+250,000
New +$2.67M
MOH icon
177
Molina Healthcare
MOH
$10.3B
$2.89M 0.06%
+29,485
New +$2.57M
CRSP icon
178
CRISPR Therapeutics
CRSP
$5.17B
$2.8M 0.06%
+47,628
New +$2.71M
LOXO
179
DELISTED
Loxo Oncology, Inc
LOXO
$2.48M 0.05%
+14,324
New +$2.15M
TCMD icon
180
Tactile Systems Technology
TCMD
$665M
$1.77M 0.04%
+33,993
New +$1.48M
AXGN icon
181
Axogen
AXGN
$2.5B
$1.74M 0.04%
+34,574
New +$1.52M
GBT
182
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.31M 0.03%
28,895
-142,162
-83% -$6.47M
A icon
183
Agilent Technologies
A
$41.2B
-209,894
Closed -$14M
AAPL icon
184
Apple
AAPL
$4.57T
-1,380,196
Closed -$57.9M
AEIS icon
185
Advanced Energy
AEIS
$13B
-80,926
Closed -$5.17M
AMN icon
186
AMN Healthcare
AMN
$1.4B
-313,746
Closed -$17.8M
AMP icon
187
Ameriprise Financial
AMP
$48.8B
-140,247
Closed -$20.7M
APD icon
188
Air Products & Chemicals
APD
$67.6B
-172,962
Closed -$27.5M
EFOR
189
Everforth Inc
EFOR
$1.32B
-630,914
Closed -$51.7M
CVSA
190
Covista Inc
CVSA
$4.8B
-146,121
Closed -$6.95M
AZTA icon
191
Azenta
AZTA
$1.48B
-109,971
Closed -$2.98M
BPMC
192
DELISTED
Blueprint Medicines
BPMC
-50,097
Closed -$4.59M
BWA icon
193
BorgWarner
BWA
$13.9B
-264,850
Closed -$11.7M
CC icon
194
Chemours
CC
$2.37B
-367,917
Closed -$17.9M
CMA
195
DELISTED
Comerica
CMA
-284,840
Closed -$27.3M
DHI icon
196
D.R. Horton
DHI
$42.3B
-863,173
Closed -$37.8M
DLTR icon
197
Dollar Tree
DLTR
$25.2B
-446,938
Closed -$42.4M
ESPR
198
DELISTED
Esperion Therapeutics
ESPR
-254,704
Closed -$18.4M
GBX icon
199
The Greenbrier Companies
GBX
$1.46B
-109,554
Closed -$5.5M
CBIO
200
Crescent Biopharma
CBIO
$626M
-5,611
Closed -$9.11M

Similar funds

Columbus Circle Investors's Q2 2018 Portfolio in Review

As of Q2 2018, Columbus Circle Investors held 228 positions worth $4.84B, down 1.7% from $4.93B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Columbus Circle Investors withdrew a net $434M in Q2 2018, closing 46 positions and reducing 84 holdings. Its most notable exit was Apple, an estimated $57.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Columbus Circle Investors opened a new position in Ulta Beauty worth $74.9M.

  • Columbus Circle Investors's largest Q2 2018 buy was Ulta Beauty: 320,928 shares worth $74.9M.
  • Columbus Circle Investors added most to Zebra Technologies in Q2 2018, an estimated $37.4M increase.
  • Columbus Circle Investors's biggest Q2 2018 reduction was Block Inc, cutting an estimated $53.8M.
  • Columbus Circle Investors fully exited Apple in Q2 2018, selling an estimated $57.9M.
  • Columbus Circle Investors's ten largest holdings make up 17% of its $4.84B portfolio in Q2 2018.
  • Columbus Circle Investors opened 50 new positions and closed 46 in Q2 2018.
  • Columbus Circle Investors's portfolio value fell 1.7% quarter-over-quarter to $4.84B.

Based on Columbus Circle Investors's 13F filing for Q2 2018, filed 24 Jul 2018.